glp-1 once weekly injection The risk of hair loss in patients taking drugs for obesity or diabetes, while low, is higher than with other diabetes drugs, new studies suggest. More details at the 🔗 in GLP-1 Journey: One Month In

If successful, menstrual bleeding will be reduced, but ablation does not shrink fibroids and will not relieve symptoms caused by the bulk or size of uterine fibroids

Excited to continue on this journey of new improved me

The findings obtained from the SMART collaborative meta-analysis (SGLT2 Inhibitor Meta-Analysis Cardio-Renal Trialists), designed to evaluate the impact of SGLT2is on cardiovascular and renal outcomes based on the concomitant use or non-use of GLP1-RAs, included 12 controlled clinical trials with 73,238 participants, of whom 3065 (4.2%) received GLP1-RAs

Alsalemi N., Sadowski C.A., Elftouh N., et al

(b) the process by which the compounded drugs are manufactured have not been reviewed by the FDA